Press Releases

Jan 04, 2022

Meridian Bioscience to Participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference

read more

Dec 02, 2021

Meridian Bioscience Announces Retirement of CFO Bryan Baldasare

read more

Nov 24, 2021

Meridian Bioscience Announces Retirement of Chairman David Phillips

read more

Nov 18, 2021

Meridian Bioscience Participates in Piper Sandler 33rd Annual Virtual Healthcare Conference

read more

Nov 17, 2021

Meridian Launches Two New Air-Dryable™ Mixes for Isothermal Amplification, Powering Shortest Time-to-results in Point-of-care Testing

read more

Nov 12, 2021

Meridian Bioscience Reports Strong Fourth Quarter And Record Full-Year Fiscal 2021 Operating Results And Provides Fiscal 2022 Guidance

read more

Nov 10, 2021

Meridian Bioscience Receives FDA Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay

read more

Oct 27, 2021

Meridian Launches Innovative Air-Dryable™ qPCR Mixes Enabling Direct Detection of DNA or RNA from Urine Samples

read more

Oct 14, 2021

Meridian Bioscience to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on November 12, 2021

read more

Oct 07, 2021

Meridian Launches New Air-Dryable™ qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples

read more

Sep 09, 2021

Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Stool Samples

read more

Sep 07, 2021

Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Saliva Samples

read more

Sep 01, 2021

Meridian Bioscience, Inc.: Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare Test Kits

read more

Aug 30, 2021

Meridian Bioscience to Present at the H. C. Wainwright 23rd Annual Global Investment Conference

read more

Aug 06, 2021

Meridian Bioscience Reports Third Quarter Fiscal 2021 Results

read more

Aug 02, 2021

Meridian Closes Acquisition of BreathTek® Business

read more

Jul 23, 2021

Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.

read more

Jul 14, 2021

Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021

read more

Jul 13, 2021

Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Third Quarter

read more

Jun 28, 2021

Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay

read more